ArticleFrontiers in oncology2020

Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway.

Zhen-Qi Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.